China-based Teddy Clinical Research Laboratory Limited, a joint venture (JV) between Dian Diagnostics (SHE: 300244) and Tigermed (SHE: 300347, HKG: 3347), has struck a partnership with Belgium-headquartered Cerba Healthcare’s subsidiary Cerba Research. The two companies will set up a JV in Wuxi, Jiangsu Province, China, marking a significant expansion of their collaborative efforts.
Historical Collaboration and New JV
The two first teamed up in 2012, working together on special testing projects, technology transfer, comprehensive clinical trial management, and logistics support services. This stepped-up partnership will leverage Teddy’s high-quality central lab solutions in China and Cerba Research’s expertise in immune-oncology, cell and gene therapy, vaccines, and infectious diseases to provide services around the world.
Global Service Expansion
The new JV aims to enhance the global reach of both companies by combining Teddy’s robust laboratory capabilities with Cerba Research’s specialized knowledge in various therapeutic areas. This collaboration is expected to offer a comprehensive suite of services to clients worldwide, enhancing the quality and efficiency of clinical research and development.-Fineline Info & Tech
